These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22325709)

  • 1. [To improve quality healthcare does not imply publicly funding any drug].
    Amado Guirado E; Diego L; Ortún V
    Aten Primaria; 2012 Apr; 44(4):187-9. PubMed ID: 22325709
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drugs withdrawn from public funding].
    Buitrago Ramirez F; Pérez Caballero FL
    Aten Primaria; 2013 Jan; 45(1):3-5. PubMed ID: 22981134
    [No Abstract]   [Full Text] [Related]  

  • 3. Public research funding and pharmaceutical prices: do Americans pay twice for drugs?
    Conti RM; David FS
    F1000Res; 2020; 9():707. PubMed ID: 33204410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secrecy on cost of publicly funded hep C treatment.
    Webster P
    CMAJ; 2017 Apr; 189(16):E617-E618. PubMed ID: 28438961
    [No Abstract]   [Full Text] [Related]  

  • 5. Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?
    Sarpatwari A; Avorn J; Kesselheim AS
    BMJ; 2020 Oct; 371():m3841. PubMed ID: 33032982
    [No Abstract]   [Full Text] [Related]  

  • 6. A tricky path to pay-for- performance drug pricing.
    Rubenfire A
    Mod Healthc; 2016 Dec; 46(50):16-18. PubMed ID: 30428190
    [No Abstract]   [Full Text] [Related]  

  • 7. Is money spent on quality improvement better spent on clinical care?
    Meyer RJ
    Med J Aust; 2011 Oct; 195(8):452. PubMed ID: 22004392
    [No Abstract]   [Full Text] [Related]  

  • 8. Is money spent on quality improvement better spent on clinical care? - No.
    Runciman WB
    Med J Aust; 2011 Jun; 194(12):641. PubMed ID: 21692722
    [No Abstract]   [Full Text] [Related]  

  • 9. Can we improve care and save money?
    Foster S
    Br J Nurs; 2017 Dec; 26(22):1267. PubMed ID: 29240472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healing an ailing pharmaceutical system: prescription for reform for United States and Canada.
    Gaffney A; Lexchin J; ;
    BMJ; 2018 May; 361():k1039. PubMed ID: 29773533
    [No Abstract]   [Full Text] [Related]  

  • 11. McKesson settling up. $190 million payment latest in drug-price flap.
    Carlson J
    Mod Healthc; 2012 Apr; 42(18):14. PubMed ID: 22667036
    [No Abstract]   [Full Text] [Related]  

  • 12. £90m package to improve dementia care is announced in England.
    Wise J
    BMJ; 2014 Mar; 348():g1879. PubMed ID: 24591459
    [No Abstract]   [Full Text] [Related]  

  • 13. Trade bill hits QIOs. Program being regionalized as a funding offset.
    Zigmond J
    Mod Healthc; 2011 Oct; 41(42):8-9. PubMed ID: 22049778
    [No Abstract]   [Full Text] [Related]  

  • 14. Is money spent on quality improvement better spent on clinical care? - Yes.
    Millar JA
    Med J Aust; 2011 Jun; 194(12):640. PubMed ID: 21692721
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescribed Drug Spending in Canada, 2019: A Focus on Public Drug Programs.
    Lee K; Jani T; Cheng R; Hunt J
    Healthc Q; 2020 Apr; 23(1):10-12. PubMed ID: 32249733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing the power of health taxes.
    Jain V; Baker P; Chalkidou K
    BMJ; 2020 Jun; 369():m1436. PubMed ID: 32554704
    [No Abstract]   [Full Text] [Related]  

  • 17. Federal budget disappoints on universal pharmacare.
    Vogel L
    CMAJ; 2019 Apr; 191(14):E406-E407. PubMed ID: 30962204
    [No Abstract]   [Full Text] [Related]  

  • 18. An early look at where the federal parties stand on health care.
    Vogel L
    CMAJ; 2019 Jul; 191(29):E826-E827. PubMed ID: 31332057
    [No Abstract]   [Full Text] [Related]  

  • 19. [Funding for Health Care Innovation in Germany - New Chances for Optimized Care for Severely Mentally Ill?].
    Riedel-Heller SG; Watzke B; Härter M; König HH
    Psychiatr Prax; 2015 Oct; 42(7):353-5. PubMed ID: 26444266
    [No Abstract]   [Full Text] [Related]  

  • 20. [Impact of potentially inappropriate drug usage on health insurance business results].
    Kirschke M; Böhme J
    Versicherungsmedizin; 2014 Sep; 66(3):142-5. PubMed ID: 25272660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.